Results Snapshot
Figures in Cr
Standalone - Balance Sheet Results
Mar'25
Mar'24
Mar'23
Mar'22
Mar'21
Mar'20
Balance Sheet Analysis Highlights
Borrowings
No Borrowings in the last few periods;
Other Long Term Liabilities
YoY Growth in year ended Mar 2025 is 9.79% vs 44.00% in Mar 2024
Fixed Assets
YoY Growth in year ended Mar 2025 is 9,375.82% vs -95.04% in Mar 2024
Investments
YoY Growth in year ended Mar 2025 is 0.00% vs -100.00% in Mar 2024
Current Assets
YoY Growth in year ended Mar 2025 is -18.09% vs 19.58% in Mar 2024
Compare Balance Sheet Results of Jagsonpal Pharma
Figures in Cr
Standalone - Balance Sheet Results
Change(INR)
Change(%)
No of Months
12
12
EQUITY AND LIABILITIES
Share Capital
13.28
2.89
10.39
359.52%
Share Warrants & Outstandings
Total Reserve
204.71
323.72
-119.01
-36.76%
Shareholder's Funds
239.95
326.61
-86.66
-26.53%
Minority Interest
0.00
0.00
0.00
0.00%
Long-Term Borrowings
0.00
0.00
0.00
0.00%
Secured Loans
0.00
0.00
0.00
0.00%
Unsecured Loans
0.00
0.00
0.00
0.00%
Deferred Tax Assets / Liabilities
3.07
-3.11
6.18
198.71%
Other Long Term Liabilities
8.30
1.89
6.41
339.15%
Long Term Trade Payables
0.00
0.00
0.00
0.00%
Long Term Provisions
1.04
8.30
-7.26
-87.47%
Total Non-Current Liabilities
12.41
7.08
5.33
75.28%
Current Liabilities
Trade Payables
9.73
69.04
-59.31
-85.91%
Other Current Liabilities
15.16
13.20
1.96
14.85%
Short Term Borrowings
0.00
0.00
0.00
0.00%
Short Term Provisions
1.01
2.34
-1.33
-56.84%
Total Current Liabilities
25.90
84.58
-58.68
-69.38%
Total Liabilities
278.26
418.28
-140.02
-33.48%
ASSETS
Non-Current Assets
0.00
0.00
0.00
0.00%
Gross Block
93.47
79.36
14.11
17.78%
Less: Accumulated Depreciation
7.25
31.83
-24.58
-77.22%
Less : Impairment of Assets
0.00
0.00
0.00
0.00%
Net Block
86.23
47.52
38.71
81.46%
Lease Adjustment
0.00
0.00
0.00
0.00%
Capital Work in Progress
0.00
16.20
-16.20
-100.00%
Intangible assets under development
0.00
0.05
-0.05
-100.00%
Pre-operative Expenses pending
0.00
0.00
0.00
0.00%
Assets in transit
0.00
0.00
0.00
0.00%
Non Current Investments
0.00
0.05
-0.05
-100.00%
Long Term Loans & Advances
1.33
20.31
-18.98
-93.45%
Other Non Current Assets
21.29
41.60
-20.31
-48.82%
Total Non-Current Assets
117.07
127.61
-10.54
-8.26%
Current Assets Loans & Advances
Current Investments
0.00
0.00
0.00
0.00%
Inventories
15.20
27.26
-12.06
-44.24%
Sundry Debtors
13.18
55.82
-42.64
-76.39%
Cash and Bank
128.73
83.16
45.57
54.80%
Other Current Assets
1.66
1.06
0.60
56.60%
Short Term Loans and Advances
2.42
123.37
-120.95
-98.04%
Total Current Assets
161.19
290.67
-129.48
-44.55%
Net Current Assets (Including Current Investments)
135.29
206.09
-70.80
-34.35%
Total Current Assets Excluding Current Investments
161.19
290.67
-129.48
-44.55%
Miscellaneous Expenses not written off
0.00
0.00
0.00
0.00%
Total Assets
278.26
418.28
-140.02
-33.48%
Contingent Liabilities
16.17
15.77
0.40
2.54%
Total Debt
0.00
0.00
0.00
0.00%
Book Value per share (adjusted)
36.08
112.97
-76.89
-68.06%
Annual - Borrowings
Borrowings 0.00 Cr
in Mar 2025Figures in Cr
No Borrowings in the last few periods;
Annual - Other Long Term Liabilities
Other Long Term Liabilities 8.30 Cr
in Mar 2025Figures in Cr
YoY Growth in year ended Mar 2025 is 9.79% vs 44.00% in Mar 2024
Annual - Fixed Assets
Fixed Assets 86.23 Cr
in Mar 2025Figures in Cr
YoY Growth in year ended Mar 2025 is 9,375.82% vs -95.04% in Mar 2024
Annual - Investments
Investments 0.00 Cr
in Mar 2025Figures in Cr
YoY Growth in year ended Mar 2025 is 0.00% vs -100.00% in Mar 2024
Annual - Current Assets
Current Assets 161.19 Cr
in Mar 2025Figures in Cr
YoY Growth in year ended Mar 2025 is -18.09% vs 19.58% in Mar 2024






